Publication Date

1-1-2021

Document Type

Article

Publication Title

Pharmacoepidemiology and Drug Safety

Volume

30

Issue

1

DOI

10.1002/pds.5101

First Page

4

Last Page

8

Comments

This is the peer reviewed version of the following article: Gerstman, BB. Proton pump inhibitors and chronic kidney disease: Reevaluating the evidence from a randomized controlled trial. Pharmacoepidemiol Drug Saf. 2021; 30: 4-8, which has been published in final form at https://doi.org/10.1002/pds.5101. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. This article may not be enhanced, enriched or otherwise transformed into a derivative work, without express permission from Wiley or by statutory rights under applicable legislation. Copyright notices must not be removed, obscured or modified. The article must be linked to Wiley’s version of record on Wiley Online Library and any embedding, framing or otherwise making available the article or pages thereof by third parties from platforms, services and websites other than Wiley Online Library must be prohibited.

Department

Public Health and Recreation

Download

Share

COinS